The value of novel immuno-oncology treatments. [electronic resource]
Producer: 20191126Description: e380-e385 p. digitalISSN:- 1936-2692
- Adult
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cost-Benefit Analysis
- Female
- Humans
- Ipilimumab -- economics
- Kaplan-Meier Estimate
- Lung Neoplasms -- drug therapy
- Male
- Melanoma -- drug therapy
- Models, Economic
- Nivolumab -- economics
- Skin Neoplasms -- drug therapy
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.